acrivastine
Sign in to saveAlso known as BW 825C, (E)-6-((E)-3-(1-Pyrrolidinyl)-1-p-tolylpropenyl)-2-pyridineacrylic acid, BW A825C, (2E)-3-{6-[(1E)-1-(4-methylphenyl)-3-(pyrrolidin-1-yl)prop-1-en-1-yl]pyridin-2-yl}acrylic acid
Acrivastine is a medication used for the treatment of allergies and hay fever. It is a second-generation H1-receptor antagonist antihistamine (like its base molecule triprolidine) and works by blocking histamine H1 receptors.
Research
112 papers- Acrivastine.2006
- Acrivastine.2012
- Acrivastine. A review of its pharmacological properties and therapeutic efficacy in allergic rhinitis, urticaria and related disorders.Drugs · 1991
- Second-generation antihistamines: a comparative review.Drugs · 1999
- Acrivastine in allergic rhinitis: a review of clinical experience.The Journal of international medical research · 1989
via PubMed
~3 min read
Encyclopedic overview
2 sectionsContents
- Comparisons with other popular antihistamines
- References
{{Drugbox | Verifiedfields = changed | verifiedrevid = 477241254 | IUPAC_name = (E)-3-{6-[(E)-1-(4-methylphenyl)-3-pyrrolidin-1-yl-prop-1-enyl]pyridin-2-yl}prop-2-enoic acid | image = Acrivastine.svg | image_class = skin-invert-image
| tradename = | Drugs.com = | pregnancy_AU = | legal_AU = | legal_CA = | legal_UK = GSL | legal_US = Rx-only | routes_of_administration = By mouth
Excerpted from Wikipedia’s “acrivastine” article, available under the CC BY-SA 4.0 licence.